Cancer News and Research

Latest Cancer News and Research

Transient absorption tracks carbon nanotubes in living cells and bloodstream

Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine.

6 Dec 2011

UH receives HP/Intel Mission-Critical Innovation Award

In a world-wide competition, University Hospitals (UH) received the Mission-Critical Innovation Award - Humanitarian/Environmental Impact category presented by the multinational information technology companies Hewlett-Packard (HP) and Intel. The award recognizes UH's leadership in information technology for groundbreaking work in developing solutions for mission-critical computing.

6 Dec 2011

Breast cancer patients might experience prolonged fatigue years after chemotherapy

In a follow-up study, researchers at Moffitt Cancer Center and colleagues have found that patients who receive chemotherapy for breast cancer might experience prolonged fatigue years after their therapy.

6 Dec 2011

Bush launches Pink Ribbon Red Ribbon project in Zambia

"Zambian President Michael Sata on Friday told former U.S. president George W. Bush that the West should help fight the scourge of maternal deaths in sub-Saharan Africa," Agence France-Presse reports, adding, "Bush is in Zambia on the second stop of a three-nation trip aimed at promoting efforts to fight diseases like cancer, AIDS and malaria."

6 Dec 2011

FDA assigns CTIs' pixantrone NDA new PDUFA action date

Cell Therapeutics, Inc. today announced that the U.S. Food and Drug Administration's Division of Oncology Products 1 has notified CTI that CTI's October 2011 resubmitted New Drug Application is considered a complete, Class 2 response to the FDA's April 2010 complete response letter.

6 Dec 2011

UK researchers to study differences in cancer survival in Appalachia

University of Kentucky researchers recently received a $225,000 grant to study the differences in cancer survival in Appalachia.

6 Dec 2011

Bold move by Astra Zeneca to share 22 early stage potential drugs with MRC

Drug maker AstraZeneca will be sharing 22 of its early-stage research compounds with the Medical Research Council as part of a make over of life sciences research. This would speed up patients’ access to breakthrough drugs and arrest the decline of research and development in the UK.

6 Dec 2011

Aspirin decreases risk of major complications from cardiac surgery

Aspirin taken within five days of cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, a lengthy intensive care unit stay and even early death (30-day mortality), according to a study by researchers at Thomas Jefferson University and UC Davis Medical Center set to appear in the journal Annals of Surgery.

6 Dec 2011

Headaches after TBI more prevalent among adolescents, girls

More than half a million children in the U.S. sustain a traumatic brain injury (TBI) every year. Adults who suffer TBI often report headaches afterward, but little is known about how often children suffer headaches after similar injuries. In a significant new study, "Headache After Pediatric Traumatic Brain Injury: A Cohort Study," researchers analyzed the prevalence of headaches three and 12 months after mild, moderate or severe TBI in children ages 5 to 17, and discovered the risk of headache was higher in adolescents (ages 13 to 17) and in girls.

6 Dec 2011

Cameron says all NHS patients should share their medical data for research

According to British Prime Minister David Cameron, every NHS patient should be a “research patient” with their medical details “opened up” to private healthcare firms. The PM announced that all those who use the NHS in England will be helping in the fight against disease by helping advance research. He hopes the result will be that patients get faster access to new treatments and Britain's life sciences sector will become a world leader.

6 Dec 2011

Tips to keep kids safe during cold-weather

Cold winds, icy rain and, in some places, snow—Old Man Winter has arrived. His entry reminds us to get our furnaces checked and winterize our car, but what about the kids? "Children are even more vulnerable than adults to cold-weather and winter-related injuries," said Dr. Karen Judy, pediatrician at Loyola University Health System and professor of pediatrics at Loyola University Chicago Stritch School of Medicine.

6 Dec 2011

Roche signs agreement to acquire Verum Diagnostica

Roche announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany.

From Roche Sequencing and Life Science 6 Dec 2011

Acupuncture for chemotherapy-induced peripheral neuropathy

Acupuncture may help ease the severe nerve pain associated with certain cancer drugs, suggests a small preliminary study published in Acupuncture in Medicine.

5 Dec 2011

Stem cells for the damaged heart

Stem cell research got its latest boost. For the first time, stem cells were injected into the hearts of humans who had suffered serious heart damage, and patients improved dramatically. The scientists found that the stem cells grew into new heart cells to replace the damaged tissue.

5 Dec 2011

Competition among institutions for doctors, scientists grabs headlines

Some big name health facilities sometimes draw entire physician or research groups from other institutions.

5 Dec 2011

Factors associated with increased risk of in-hospital falls after total hip or knee replacement surgery

Investigators from Hospital for Special Surgery have identified factors that are associated with an increased risk of in-hospital falls after total hip or knee replacement surgery.

5 Dec 2011

Towards a national plan of action for rare diseases

"Rare diseases", by their very definition, occur in no more than 5 people out of every 10,000 inhabitants. Barely noticed by the general public, only around 1,000 of the currently 6,000 or so different rare diseases currently listed on the Internet platform Orphanet are treatable nowadays.

5 Dec 2011

Unigene acquires exclusive worldwide rights to oral PTH program from GSK

Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.

5 Dec 2011

Genetic variation predicts survival chances of ovarian cancer

Yale Cancer Center researchers have shown that a tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer.

5 Dec 2011

Growth hormone PDGF-BB and blood protein EPO implicated in development of cancer

Researchers at the Swedish medical university Karolinska Institutet have demonstrated that a growth hormone, PDGF-BB, and the blood protein EPO are involved in the development of cancer tumours and that they combine to help the tumours proliferate in the body.

5 Dec 2011